Speaker Series: Immune-mediated inflammatory diseases - part 1

In this review:

This publication summarises the presentations focussing on PROs (patient-reported outcomes) that were part of the IMID (immune-mediated inflammatory disease) meeting held in Auckland on Sept 29–30. IMID, which was sponsored by AbbVie NZ, was an educational meeting developed by a steering committee for enhancing medical knowledge and scientific exchange. Dr. Jakob Begun spoke on translating PROs into trials and clinical practice, and Dr. Andrew McCombie talked about their role in eHealth solutions. We hope you find the information in the publication helpful.

Download PDF Subscribe